Showing 3 Result(s)

Progressive Multifocal Leukoencephalopathy (PML)

Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS patients using immunosuppressive therapies. Awareness of the risk factors, regular monitoring, and open communication with healthcare providers are essential for MS patients considering or currently using these medications.

Epilepsy (SUDEP)

Epilepsy affects millions of people worldwide, and it is estimated that one in 26 people will develop epilepsy at some point in their lives.